Meticulous Research– a leading global market research company published a research report titled “Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027”.
According to this latest publication fsssrom Meticulous Research, the research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to reach USD 6.32 billion by 2027. Increasing proteomics & genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the research antibodies and reagents market. Also, rising stem cell research, emerging economies, rising biomarker discovery, and increasing protein-based research are stimulating this market's growth. However, factors such as high cost and time related to identifying & developing potential antibodies hinder the market's growth.
Research Antibodies and Reagents Market: Future Outlook
The research antibodies and reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027. The research antibodies and reagents market study includes the market analysis by Product {Antibodies [Type (Primary Antibody, Secondary Antibody), Production Type (Monoclonal Antibody, Polyclonal Antibody, and Antibody Fragments), Source (Mouse, Rabbit, and others), Research Area (Oncology, Cardiovascular Disease, Infectious Diseases, Immunology, Neurology, Stem Cell Research, and Others)], Reagents [Sample Preparation Reagents (Media and Serum, Stain and Dyes, Probes, Buffers, and Solvents), Antibody Production Reagents (Enzymes and Proteins), Other Research Reagents}, Technology (Western Blot, Immunofluorescence, ELISA, Multiplex Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, and Others), Application (Proteomics, Drug Discovery and Development, and Genomics), End User (Pharmaceutical and Biotechnology Industry, Academic and Research Institutes, and Contract Research Organizations), and Geography. The study also evaluates industry competitors and the market at the regional and country levels.
Based on product, the reagents segment is projected to grow at the fastest rate of the overall research antibodies and reagents market. This can be attributed to the growing demand for various reagents in many routine assays and techniques, increasing focus on understanding the molecular basis of diseases, routine use in target-based assays during basic research, rising focus on product innovation, and increasing demand for technologically advanced reagents.
In 2020, the flow cytometry segment is poised to command the largest share of the research antibodies and reagents market. Raising demand for antibody & cell-based research and rising biomarker discovery are the factors driving the growth of this segment.
In 2020, the proteomics segment is poised to command the largest share of the research antibodies and reagents market. Growing focus on proteomics research, increasing uptake of antibodies for proteomics, and rising need for designing more effective drugs through protein-based disease profiling are the factors driving the growth of this segment.
In 2020, the pharmaceutical and biotechnology industry segment is poised to command the largest share of the research antibodies and reagents market. The larger adoption of antibodies for proteomics research and drug discovery & development by this end-user is driving the growth of this segment.
This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia Pacific), Latin America, and the Middle East & Africa.
In 2020, Asia-Pacific is projected to dominate the research antibodies and reagents market, followed by Europe and North America. Emerging economies, low regulatory hindrance, improving healthcare infrastructure, rising middle-income people, rising accessibility to healthcare services & products, and continuous R&D development in the pharma & biotech sector are the factors driving the APAC market.
The key players operating in the research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.).
Key questions answered in the report-
· Which are the high growth market segments in terms of product, technology, application, end-user, and region/countries?
· What was the historicsal market for research antibodies and reagents across the globe?
· What are the market forecasts and estimates for the period 2020-2027?
· What are the major drivers, restraints, opportunities, and trends in the research antibodies and reagents market?
· Who are the major players in the research antibodies and reagents market?
· How is the competitive landscape, and who are the market leaders in the research antibodies and reagents market?
· What are the recent developments in the research antibodies and reagents market?
· What are the different strategies adopted by the major players in the research antibodies and reagents market?
· What are the geographical trends and high growth regions/countries?
Get Sample Report with all Graphs & Charts related to it @ https://www.meticulousresearch.com/download-sample-report/cp_id=5055
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
According to the new market research report "Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R activity and expenditure in the life sciences industry.
Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years.Browse in-depth TOC on "Research Antibodies and Reagents Market"220 – Tables 45 – Figures 278 – PagesDownload PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection.
As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19.
The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.The antibodies segment is expected to grow at the highest CAGR during the forecast periodBased on product, the research antibodies market is segmented into reagents and antibodies.
The primary antibodies segment held the largest share of the global research antibodies market in 2019.
Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoptionThe media & sera reagent is expected to account for the largest share of the market, by type, in 2019Based type, the research antibodies and reagents market is segmented into media , stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents.
Global Research Antibodies and Reagents Scope and Market SizeResearch Antibodies and Reagents market is segmented by company, region (country), by Type, and by Application.
Players, stakeholders, and other participants in the global Research Antibodies and Reagents market will be able to gain the upper hand as they use the report as a powerful resource.
The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6350840/global-linear-particle-accelerators-2021-633Segment by TypeFlow CytometryELISAImmunofluorescenceWestern BlottingOthersSegment by ApplicationPharmaceutical & Biotechnological CompaniesAcademic & Research InstitutesContract Research OrganizationsOthersBy RegionNorth AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of AsiaLatin AmericaMexicoBrazilRest of Latin AmericaMiddle East & AfricaTurkeySaudi ArabiaUAERest of MEABy CompanyThermo Fisher ScientificMerck MilliporeDanaherSiemens HealthcareBio-Rad LaboratoriesRocheSysmexPerkinElmerAbcamBDAgilent TechnologiesReasons to Purchase Our Research Report:1.
Market dynamics scenario, along with growth opportunities of the market in the years to come3.
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects4.
Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.5.
The 5G enterprise market size is predicted to reach USD 31.4 billion by 2027 according to a new study by Polaris Market Research.
The report “5G Enterprise Market Share, Size, Trends, Industry Analysis Report, By Access Equipment Type (Radio Node, service Node, DAS); By Core Network Technology (SDN, NFV); By Service(Platform and Software); By Organization Size(SMEs, Large Enterprises); By End User (BFSI, Media and Entertainment, Retail and Ecommerce, Healthcare and Life Sciences, Government and Defense, Transportation and Logistics, Manufacturing, Agriculture, IT and Telecommunications, Others); By Regions; Segment Forecast, 2020 –2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
5G is the latest model of the cellular mobile communications with updated and latest technology is very speedy and when combining with new innovative technologies such as Internet of things and smart manufacturing capabilities are going to generate a whole exquisite experience for the customer.
They will establish new connectivity, which will assist the businesses to widen their capabilities.
Recent developments in the market include X50 (baseband), X55 (baseband), X60 (baseband), Snapdragon 765 and 765G, Snapdragon Serie 6, Exynos 5100, Dimensity 1000L SoC / MT6885 based on Helio M70 and Makalu Ivy510.
These instruments offer new and advanced technological features and supports 5G NR radio interference.Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/5g-enterprise-market/request-for-sample The prominent factors favoring the global market growth include rising demand of smartphones with advanced features and increasing demand for single network to allow several industries coupling with increasing new developments.
